Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer
Abstract Background The objective of this study was to compare the efficacy and safety of subsequent chemotherapy with single eribulin or utidelone combined with a capecitabine regimen in patients with advanced breast cancer who had previously been treated with anthracyclines and paclitaxel. Methods...
Saved in:
| Main Authors: | Mengya Feng, Pingping Bi, Yihua Kang, Dechun Yang, Shengnan Ren, Xianping Lu, Guojian Xie, Hai Lei, Dan Mo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-024-03608-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma
by: Miaomiao Zhang, et al.
Published: (2025-01-01) -
Eribulin mesylate exerts antitumor effects via CD103
by: Kazumasa Oya, et al.
Published: (2023-12-01) -
Adherence and safety study in patients on treatment with capecitabine
by: Francisca Fernández-Ribeiro, et al.
Published: (2017-03-01) -
Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer
by: Amanda Truong, MD, PhD, et al.
Published: (2024-12-01) -
Therapeutic Levels of Acetaminophen Causing AKI: A Case Report and Literature Review
by: Hamnah Tayyab, et al.
Published: (2025-01-01)